SCHEMBL21476801

SCHEMBL21476801

c1ccc(-c2cccc(-c3nc(-c4ccc(-c5c6ccccc6c(-c6ccccc6)c6ccccc56)cc4)nc(-c4cc5ccccc5o4)n3)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.43
PLA2G4A P47712 4/20 0.43
MAOB P27338 2/20 0.43
MAOA P21397 1/20 0.43
PLA2G10 O15496 1/20 0.40
ALOX5 P09917 1/20 0.40
RAB9A P51151 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAPT P10636 3/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP19A1 P11511 1/20 0.38
PGR P06401 1/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21476822 0.99 PLA2G2A (0.42) PLA2G2APLA2G4AMAOBMAOAPLA2G10
SCHEMBL21476800 0.97 PLA2G2A (0.43) PLA2G2APLA2G4AMAOBMAOAPLA2G10
SCHEMBL21476828 0.95 MAOB (0.43) PLA2G2APLA2G4AMAOBMAOAPLA2G10
SCHEMBL24226005 0.95 MAOB (0.44) PLA2G2APLA2G4AMAOBMAOAALOX5
SCHEMBL21476470 0.95 MAOB (0.45) PLA2G2APLA2G4AMAOBMAOAALOX5
SCHEMBL21476574 0.93 MAOB (0.46) PLA2G2APLA2G4AMAOBMAOAALOX5
SCHEMBL21476826 0.93 RAB9A (0.40) PLA2G2APLA2G4AMAOBMAOAPLA2G10
SCHEMBL21476799 0.92 MAOB (0.43) PLA2G2APLA2G4AMAOBMAOAALOX5
SCHEMBL21476823 0.90 KDM4E (0.43) PLA2G2APLA2G4AMAOBMAOAALOX5
SCHEMBL21476601 0.89 MAOB (0.43) PLA2G2APLA2G4AMAOBMAOAALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210130336-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2021-05-06 US disclosed
WO-2019198806-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2019-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210130336-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, MLX, LEF1 PLA2G2A 3064/4885PLA2G4A 4054/4885MAOB 2115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.